|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
EP0377676B1
(en)
|
1987-09-17 |
1995-05-24 |
Massachusetts Institute Of Technology |
Human erythroid-specific transcriptional enhancer
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
AU8200191A
(en)
|
1990-07-09 |
1992-02-04 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
JP3866760B2
(ja)
|
1993-02-22 |
2007-01-10 |
ザ ロックフェラー ユニバーシティ |
一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
JPH10501686A
(ja)
|
1994-04-13 |
1998-02-17 |
ザ ロックフェラー ユニヴァーシティ |
神経系の細胞へのdnaのaav仲介送達
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
HK1050210B
(en)
|
1999-10-12 |
2007-08-24 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(cg-RX-API-DMAC7.html)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
CA2462628C
(en)
|
2001-10-02 |
2019-08-20 |
Institut Clayton De La Recherche |
Restricted expression lentiviral vectors
|
|
CN103589692B
(zh)
|
2001-11-13 |
2018-07-24 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
ATE446077T1
(de)
|
2002-05-02 |
2009-11-15 |
Univ Rochester |
Vektoren mit beiden isoformen von beta- hexosaminidase
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
JP2005535318A
(ja)
|
2002-08-12 |
2005-11-24 |
ユニヴェルシテ ドゥ シェルブルック |
プレメッセンジャーrnaのスプライス部位選択の再プログラミング方法
|
|
WO2004094642A2
(en)
|
2003-04-24 |
2004-11-04 |
Fondazione Centro San Raffaele Del Monte Tabor |
Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
US20060171935A1
(en)
|
2005-01-31 |
2006-08-03 |
Asa Abeliovich |
Protecting cell therapy for neurological disorders including Parkinson's disease
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
AU2008262478B9
(en)
|
2007-05-29 |
2014-06-19 |
Aldevron, L.L.C. |
Vectors and methods for genetic immunization
|
|
CA2693712C
(en)
|
2007-07-14 |
2018-05-29 |
The University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
WO2009026116A2
(en)
|
2007-08-16 |
2009-02-26 |
Genizon Biosciences, Inc. |
Genemap of the human genes associated with longevity
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
WO2011053825A2
(en)
|
2009-10-30 |
2011-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment or prevention of mitochondrial diseases
|
|
CA2793692A1
(en)
|
2010-04-02 |
2011-10-06 |
Ceregene, Inc. |
Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
|
|
US8603994B2
(en)
|
2010-11-11 |
2013-12-10 |
Valted, Llc |
Transcriptional repression leading to Parkinson's disease
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
BR112014020325A2
(pt)
|
2012-02-17 |
2017-08-08 |
Childrens Hospital Philadelphia |
composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
|
|
WO2013151664A1
(en)
*
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
CN116622704A
(zh)
|
2012-07-25 |
2023-08-22 |
布罗德研究所有限公司 |
可诱导的dna结合蛋白和基因组干扰工具及其应用
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
WO2015060722A1
(en)
*
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
EP3760719A1
(en)
|
2013-11-18 |
2021-01-06 |
CRISPR Therapeutics AG |
Crispr-cas system materials and methods
|
|
SG11201608701QA
(en)
|
2014-04-18 |
2016-11-29 |
Editas Medicine Inc |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
CA2947466A1
(en)
|
2014-05-01 |
2015-11-05 |
University Of Washington |
In vivo gene engineering with adenoviral vectors
|
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
US11030531B2
(en)
|
2014-06-06 |
2021-06-08 |
Trustees Of Boston University |
DNA recombinase circuits for logical control of gene expression
|
|
US10781459B2
(en)
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
MX2017011615A
(es)
|
2015-03-10 |
2018-04-11 |
Univ Columbia |
Construcciones de vectores virales adeno-asociados de glut1 recombinantes y métodos relacionados para restablecer la expresión de glut1.
|
|
WO2016200543A2
(en)
|
2015-05-13 |
2016-12-15 |
The Trustees Of The University Of Pennsylvania |
Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
|
|
US20170029798A1
(en)
|
2015-07-27 |
2017-02-02 |
Cellivery Therapeutics, Inc. |
Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
AU2016366549B2
(en)
|
2015-12-11 |
2022-11-10 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
|
EP3405215B1
(en)
|
2016-01-19 |
2022-06-15 |
The Regents of the University of California |
Methods for the treatment of danon disease and other disorders of autophagy
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
KR102673203B1
(ko)
|
2016-04-20 |
2024-06-10 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
Pklr의 유전자 발현 증강을 위한 조성물 및 방법
|
|
CA3028334A1
(en)
*
|
2016-06-29 |
2018-01-04 |
Ramot At Tel-Aviv University Ltd. |
Engineered parasites for delivering protein to the central nervous system (cns)
|
|
IL320371A
(en)
|
2016-09-08 |
2025-06-01 |
Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P |
Gene therapy for patients with fanconi anemia
|
|
EP3519569B1
(en)
|
2016-09-30 |
2020-12-02 |
Esteve Pharmaceuticals, S.A. |
Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
EP3615044A4
(en)
|
2017-04-27 |
2021-01-20 |
Fred Hutchinson Cancer Research Center |
THERAPEUTIC FORMULAS CONTAINING CD34 + STEM CELLS DERIVED FROM NEGATIVE SELECTION
|
|
AU2018352583B2
(en)
|
2017-10-16 |
2025-04-17 |
Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. |
Lentiviral vectors for delivery of PKLR to treat Pyruvate Kinase Deficiency
|
|
US12539316B2
(en)
|
2018-04-11 |
2026-02-03 |
Spacecraft Seven, Llc |
Compositions and methods for stem cell transplant
|
|
IL278213B2
(en)
|
2018-04-27 |
2026-04-01 |
Rocket Pharmaceuticals Ltd |
A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
|
|
CA3097375A1
(en)
|
2018-04-27 |
2019-10-31 |
Universitat Heidelberg |
Modified aav capsid polypeptides for treatment of muscular diseases
|
|
EP3820537A4
(en)
|
2018-07-12 |
2022-04-13 |
Spacecraft Seven, LLC |
GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE
|
|
IL280465B2
(en)
|
2018-07-30 |
2025-03-01 |
Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P |
Methods for gene modification of hematopoietic cells
|
|
WO2020033842A1
(en)
|
2018-08-10 |
2020-02-13 |
Regenxbio Inc. |
Scalable method for recombinant aav production
|
|
JP2021533831A
(ja)
|
2018-08-16 |
2021-12-09 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ウイルスベクターのための生成方法
|
|
US20220143215A1
(en)
|
2019-02-12 |
2022-05-12 |
Spacecraft Seven, Llc |
Gene therapy vectors for treatment of danon disease
|
|
KR20220012266A
(ko)
|
2019-05-23 |
2022-02-03 |
스페이스크래프트 세븐, 엘엘씨 |
영아 악성 골화석증을 위한 유전자 요법 벡터
|
|
AU2021259422A1
(en)
|
2020-04-20 |
2022-12-08 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
CA3177341A1
(en)
|
2020-05-20 |
2021-11-25 |
Chester Bittencort SACRAMENTO |
Engineered parkin and uses thereof
|
|
JP2023526449A
(ja)
|
2020-05-21 |
2023-06-21 |
ニスノバイオ ジーティー,エルエルシー |
パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
AU2021321412A1
(en)
|
2020-08-05 |
2023-04-06 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
IL300187A
(en)
|
2020-08-05 |
2023-03-01 |
Spacecraft Seven Llc |
Gene therapy CSRP3 (protein 3 rich in cysteine and glycine)
|
|
WO2022032226A1
(en)
|
2020-08-07 |
2022-02-10 |
Spacecraft Seven, Llc |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
|
CN116887868A
(zh)
|
2020-12-07 |
2023-10-13 |
太空飞船七有限责任公司 |
达农病的治疗
|
|
MX2024009685A
(es)
|
2022-02-08 |
2024-08-19 |
Spacecraft Seven Llc |
Vector viral adenoasociado para la expresion de glut1 y usos del mismo.
|